A Phase I Study of the Potent AKT Inhibitor MK-2206 in Combination With Carboplatin and Paclitaxel, Docetaxel or Erlotinib in Patients With Advanced Solid TumoursL. R. Molife, S. Minton, J. Vitfell-Pedersen,E. Chen,D. Sullivan,L. Yan, A. M. Zernhelt,L. Siu, J. S. de Bono,A. W. TolcherEuropean Journal of Cancer（2011）引用 1|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
